Patent Assignment
Reel/Frame 066371/0033
Corrective Assignment to Correct the the Assignee Name Previously Recorded at Reel: 062212 Frame: 0380. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2024-01-25
Pages: 4
Assignor
SUMITOMO CHEMICAL COMPANY, LIMITED
Executed: 2023-09-19
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Therapeutic Drug for Disease Accompanied by Disorders in Retinal Cells or Retinal Tissue
Application:
17/418,003 →
Publication:
US 2024/0207483
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 24, 2021
From: SUGITA, SUNAO; MANDAI, MICHIKO; TAKAHASHI, MASAYO; YAMASAKI, SUGURU
To: RIKEN; SUMITOMO DAINIPPON PHARMA CO., LTD.; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 056659/0705 →
Change of Name
Jul 14, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD
Reel/Frame 060507/0750 →
Assignment of Assignor's Interest
Jan 23, 2024
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: SUMITOMO PHARMA CO., LTD
Reel/Frame 066212/0380 →
Assignment of Assignor's Interest
Sep 29, 2025
From: SUMITOMO PHARMA CO., LTD.
To: RACTHERA CO., LTD.
Reel/Frame 072399/0820 →